Evidence map›Paper›PMID 30745894›Full record

ArticleFrontiers in endocrinology2018

Hypercoagulability and Risk of Venous Thromboembolic Events in Endogenous Cushing's Syndrome: A Systematic Meta-Analysis.

Jeffrey Wagner, Fabienne Langlois, Dawn Shao Ting Lim, Shirley McCartney, Maria Fleseriu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it, 117 citations in OpenAlex.

  1. The Effect of Endogenous Cushing Syndrome on All-cause and Cause-specific Mortality.The Journal of clinical endocrinology and metabolism · 2022
    Pooled it
  2. Relacorilant or surgery improved hemostatic markers in Cushing syndrome.Journal of endocrinological investigation · 2025
    Trial
  3. Article
  4. Review
  5. Observational
  6. Review
  7. Article
  8. Article
  9. Article
  10. Hypercoagulability in Cushing's syndrome: past, present, future.Archives of endocrinology and metabolism · 2025
    Review
  11. Article
  12. Thrombotic complications of glucocorticoids and anabolic steroids.Research and practice in thrombosis and haemostasis · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 3 countries.

Jeffrey WagnerNorthwest Pituitary Center, Oregon Health & Science University, Portland, OR, United States.
Fabienne LangloisNorthwest Pituitary Center, Oregon Health & Science University, Portland, OR, United States.
Dawn Shao Ting LimNorthwest Pituitary Center, Oregon Health & Science University, Portland, OR, United States.
Shirley McCartneyNorthwest Pituitary Center, Oregon Health & Science University, Portland, OR, United States.
Maria FleseriuNorthwest Pituitary Center, Oregon Health & Science University, Portland, OR, United States.
Oregon Health & Science University · USCentre Hospitalier Universitaire de Sherbrooke · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anticoagulationCushing diseaseCushing syndromehypercoagulabilityvenous thromboembolism

Identifiers

PMID30745894
PMCPMC6360168
OpenAlexW2913498470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.